Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Your ultimate guide to the 2024 North Carolina State Fair
Recommended
Find a flu shot
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Hesperos, Inc.
Hesperos Provides Support for an Investigational Product for a Phase II Clinical Trial with its Human-on-a-Chip®
September 24, 2024
From
Hesperos, Inc.
Via
Business Wire
New Study Describes a Functional, Aged, Human Cell-Based Platform That Examines the Contribution of Senescence in Alzheimer’s Disease Progression, and Response to Therapeutics
July 30, 2024
From
Hesperos, Inc.
Via
Business Wire
NIH Awards Hesperos Research Grant to Develop Animal-Free Botox Testing Platform
May 07, 2024
From
Hesperos, Inc.
Via
Business Wire
New Study Describes First, Functional Human Model to Investigate Opiate Overdose and Recovery
September 07, 2023
From
Hesperos, Inc.
Via
Business Wire
International Microphysiological Systems Society formally established at MPS World Summit, 2023
July 12, 2023
From
Hesperos, Inc.
Via
Business Wire
Hesperos Scientists Publish a New Study in Scientific Reports Titled: "Development of a Human Malaria-on-a-Chip Disease Model for Drug Efficacy and Off-Target Toxicity Evaluation"
July 05, 2023
From
Hesperos, Inc.
Via
Business Wire
Hesperos, Inc. Appoints New Chief Executive Officer, Dr. James Kronauge
May 26, 2022
From
Hesperos, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.